Literature DB >> 23891969

The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis.

Ahmed A Alkhateeb1, James R Connor.   

Abstract

The iron storage protein ferritin has been continuously studied for over 70years and its function as the primary iron storage protein in cells is well established. Although the intracellular functions of ferritin are for the most part well-characterized, the significance of serum (extracellular) ferritin in human biology is poorly understood. Recently, several lines of evidence have demonstrated that ferritin is a multi-functional protein with possible roles in proliferation, angiogenesis, immunosuppression, and iron delivery. In the context of cancer, ferritin is detected at higher levels in the sera of many cancer patients, and the higher levels correlate with aggressive disease and poor clinical outcome. Furthermore, ferritin is highly expressed in tumor-associated macrophages which have been recently recognized as having critical roles in tumor progression and therapy resistance. These characteristics suggest ferritin could be an attractive target for cancer therapy because its down-regulation could disrupt the supportive tumor microenvironment, kill cancer cells, and increase sensitivity to chemotherapy. In this review, we provide an overview of the current knowledge on the function and regulation of ferritin. Moreover, we examine the literature on ferritin's contributions to tumor progression and therapy resistance, in addition to its therapeutic potential.
© 2013.

Entities:  

Keywords:  Anti-oxidation; Ferritin; Inflammation; Iron; Serum ferritin; Tumor-associated macrophages

Mesh:

Substances:

Year:  2013        PMID: 23891969     DOI: 10.1016/j.bbcan.2013.07.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  69 in total

1.  Iron Oxidation and Core Formation in Recombinant Heteropolymeric Human Ferritins.

Authors:  Matthew Mehlenbacher; Maura Poli; Paolo Arosio; Paolo Santambrogio; Sonia Levi; N Dennis Chasteen; Fadi Bou-Abdallah
Journal:  Biochemistry       Date:  2017-07-18       Impact factor: 3.162

2.  Prognostic impact of pretransplantation hyperferritinemia in adults undergoing allogeneic hematopoietic SCT: a meta-analysis.

Authors:  Z Wang; M Jia; H Zhao; Y Cheng; Z Luo; Y Chen; X Xu; Y Tang
Journal:  Bone Marrow Transplant       Date:  2014-06-23       Impact factor: 5.483

3.  Iron depletion enhances the effect of sorafenib in hepatocarcinoma.

Authors:  Shinichi Urano; Toshiaki Ohara; Kazuhiro Noma; Ryoichi Katsube; Takayuki Ninomiya; Yasuko Tomono; Hiroshi Tazawa; Shunsuke Kagawa; Yasuhiro Shirakawa; Fumiaki Kimura; Kazuhiro Nouso; Akihiro Matsukawa; Kazuhide Yamamoto; Toshiyoshi Fujiwara
Journal:  Cancer Biol Ther       Date:  2016-04-18       Impact factor: 4.742

4.  Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer.

Authors:  Ellinor I B Peerschke; Melissa S Pessin; Peter Maslak
Journal:  Am J Clin Pathol       Date:  2014-10       Impact factor: 2.493

5.  Screening, identification of prostate cancer urinary biomarkers and verification of important spots.

Authors:  Huijun Zhao; Xuhong Zhao; Ting Lei; Man Zhang
Journal:  Invest New Drugs       Date:  2019-01-04       Impact factor: 3.850

Review 6.  Ferritins in Kidney Disease.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

7.  Extravascular type of intravascular papillary endothelial hyperplasia mimicking parotid gland neoplasia and the possible role of ferritin in the pathogenesis: A case report.

Authors:  Chiara Mignogna; Ida Barca; Anna Di Vito; Francesca Puleo; Natalia Malara; Amerigo Giudice; Mario Giudice; Tullio Barni; Giuseppe Donato; Maria Giulia Cristofaro
Journal:  Mol Clin Oncol       Date:  2016-12-23

Review 8.  [Management of chemotherapy side effects and their long-term sequelae].

Authors:  Isabella M Zraik; Yasmine Heß-Busch
Journal:  Urologe A       Date:  2021-06-29       Impact factor: 0.639

9.  Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma.

Authors:  Pınar Cömert; Abdulkerim Yıldız; Murat Yıldırım; Hacer Berna Afacan Öztürk; Çiğdem Pala; Murat Albayrak; Meltem Aylı
Journal:  Indian J Hematol Blood Transfus       Date:  2019-08-06       Impact factor: 0.900

Review 10.  Bioengineered Ferritin Nanocarriers for Cancer Therapy.

Authors:  Xuanrong Sun; Yulu Hong; Yubei Gong; Shanshan Zheng; Dehui Xie
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.